Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC)
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-03
DOI
10.1007/s00262-020-02655-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome
- (2020) Yin-Huai Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
- (2019) Jia Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: a preliminary observational study
- (2019) Yi Jiang et al. Annals of Intensive Care
- Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
- (2019) Isabel Heidegger et al. Frontiers in Oncology
- Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
- (2019) Philipp J. Stenzel et al. Translational Oncology
- Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma
- (2018) David M. Gill et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery
- (2018) Bradley C. Leibovich et al. EUROPEAN UROLOGY
- Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials
- (2018) Andrew T. Lenis et al. JOURNAL OF UROLOGY
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Second‐Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review
- (2018) Nizar M. Tannir et al. ONCOLOGIST
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses
- (2018) Larissa Lamertz et al. Science Signaling
- Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
- (2017) William P. Parker et al. EUROPEAN UROLOGY
- Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature
- (2017) Sean Didion INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual Roles of IL-27 in Cancer Biology and Immunotherapy
- (2017) Marina Fabbi et al. MEDIATORS OF INFLAMMATION
- In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients
- (2017) H. J. Aarstad et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target
- (2017) Tor Henrik Anderson Tvedt et al. Frontiers in Immunology
- Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions
- (2016) Najib Aziz et al. CYTOKINE
- A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use
- (2016) Christian Beisland et al. WORLD JOURNAL OF UROLOGY
- Nivolumab in renal cell carcinoma: latest evidence and clinical potential
- (2016) Camille Mazza et al. Therapeutic Advances in Medical Oncology
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
- (2016) Bodo E. Lippitz et al. OncoImmunology
- Association between polymorphisms inIL27gene and renal cell carcinoma
- (2015) Yan Pu et al. BIOMARKERS
- Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis
- (2015) Qiang Fu et al. BRITISH JOURNAL OF CANCER
- IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
- (2014) Koji Taniguchi et al. SEMINARS IN IMMUNOLOGY
- Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma
- (2014) Christian Beisland et al. Scandinavian Journal of Urology
- Regulatory T cells, interleukin (IL)-6, IL-8, Vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma
- (2013) Marianeve Polimeno et al. BJU INTERNATIONAL
- Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
- (2013) Jürgen Scheller et al. SEMINARS IN IMMUNOLOGY
- IL-6/IL-6 receptor system and its role in physiological and pathological conditions
- (2011) Masahiko Mihara et al. CLINICAL SCIENCE
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Major Depression Drives Severity of American Urological Association Symptom Index
- (2010) Timothy V. Johnson et al. UROLOGY
- Vascular Endothelial Growth Factor
- (2009) Napoleone Ferrara ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started